title: Neuroleptic malignant syndrome induced by metoclopramide.
abstract: Neuroleptic malignant syndrome (NMS) associated with metoclopramide is rare. NMS probably results from neuroleptic-induced dopamine receptor blockade. We describe a case and have found only seven reports of metoclopramide-induced NMS in the literature.
authors.affiliation: Clinique de Neurologie, CHU Timone, Marseille, France.
authors.forename: A
authors.initials: A
authors.lastname: Donnet
authors.forename: J R
authors.initials: JR
authors.lastname: Harle
authors.forename: J C
authors.initials: JC
authors.lastname: Dumont
authors.forename: A
authors.initials: A
authors.lastname: Alif Cherif
mesh_terms: D000368:Aged; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000009:adverse effects*; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology* / Q000503:physiopathology
chemical_list: D008787:Metoclopramide